CF
DGX icon

Centaurus Financial’s Quest Diagnostics DGX Stock Holding History

Centaurus Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,745
Closed -$273K – 910
2022
Q4 		$273K Buy
1,745
+68
+4% +$9.77K 0.03% 517
2022
Q3 		$206K Sell
1,677
-4
-0.2% -$527 0.02% 609
2022
Q2 		$224K Sell
1,681
-181
-10% -$24.7K 0.02% 577
2022
Q1 		$255K Sell
1,862
-135
-7% -$18.8K 0.02% 592
2021
Q4 		$346K Sell
1,997
-70
-3% -$10.7K 0.03% 540
2021
Q3 		$300K Buy
2,067
+34
+2% +$4.97K 0.03% 550
2021
Q2 		$268K Buy
+2,033
New +$266K 0.02% 595
2018
Q3 		– Sell
-54
Closed -$6K – 873
2018
Q2 		$6K Buy
+54
New +$5.63K ﹤0.01% 1718

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Centaurus Financial's DGX Position: Q1 2023 in Review

Centaurus Financial sold out of Quest Diagnostics (DGX) in Q1 2023, closing a stake of 1,745 shares — an estimated $273K sold.

Centaurus Financial first reported a position in DGX in Q2 2018 and held it in 8 quarters. The position peaked at $346K in Q4 2021. 834 funds tracked by Wall St. Rank hold DGX as of Q1 2023.

  • Centaurus Financial reported no remaining Quest Diagnostics position as of Q1 2023 after selling out during the quarter.
  • Centaurus Financial sold 1,745 Quest Diagnostics shares in Q1 2023, an estimated $273K.
  • Centaurus Financial first reported a position in Quest Diagnostics in Q2 2018 and held it in 8 quarters.
  • Centaurus Financial's Quest Diagnostics position peaked at $346K in Q4 2021.
  • 834 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2023.

Based on Centaurus Financial's 13F filing for Q1 2023, filed 18 May 2023.